This message was sent to ##Email##
|
|
|
|
|
AST
With the growing concern about the Coronavirus (COVID-19), the AST has published FAQ pages for both physicians and patients.
READ MORE
AST
On March 7, 2020, the American Society of Transplantation proudly presented the AST Innovation Award to Dr. Peter Reese and Dr. David Goldberg and the THINKER project, at the Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ.
READ MORE
AST
The Travel for Techniques in Transplantation Research (T3R) Program supports the travel of a scientist to the laboratory of another scientist to acquire a new technique. This program fulfills a goal of the AST Research Network to facilitate bringing novel, cutting edge techniques to transplant biology research labs and clinical scientists. The deadline to apply is March 15!
READ MORE
AST
The 2019-2020 member referral program is in full swing. All members who successfully recruit 3 new members will receive 1 year of membership free! In addition, you will be entered into the yearly prize drawing, which includes an iPad or AST bucks.
You can quickly send a personal and professional email message to refer your colleagues by clicking here.
Spread the word! Recommend colleagues for membership and earn rewards! Visit the Member-Get-A-Member page for program details and other resources.
AST
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020, also known as the Immuno Bill, was just introduced in the Senate. This legislation would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Please take a moment to contact your Senators about this important legislation (and if you haven’t already, please also reach out to your House representative to do the same!)
Contact Congress Today
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
The Transplantation Society in collaboration with the American Society of Transplantation (AST), acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards. The International Transplantation Science Mentee-Mentor Awards aim is to encourage young investigators to submit their research to TTS 2020 and help cover expenses to attend the Congress in Seoul. For more information about the awards and eligibility, click here.
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
Veloxis Pharmaceuticals
 Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft
function at 3 months and 12 months.
READ MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
| | UPCOMING EDUCATION EVENTS |
AST
March 24, 2020 | 2 pm ET | Online Activity
For more information, click here
|
|
The Journal of Heart and Lung Transplantation
Recently, Cogswell and colleagues presented analysis of changes in waitlist and post-transplant survival following modifications to the United States adult donor heart allocation system in October 2018. Based on early data from the United Network for Organ Sharing (UNOS) registry with follow-up through June 6, 2019, the analysis demonstrated a significant increase in the unadjusted hazard of post-transplant death or retransplantation up to 180 days among single-organ recipients.
READ MORE
The Journal of Heart and Lung Transplantation
The contribution of lung transplantation to the treatment of patients with end-stage cystic fibrosis has been debated. We aimed to describe achievable outcomes from high-volume CF and lung transplant programs. This study reports on the largest single-center experience of lung transplantation for adult and pediatric patients with CF. It also highlights the evolution of practice and outcomes over time.
READ MORE
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Transplantation Journal
Patients with nonalcoholic steatohepatitis (NASH) are waitlisted at older ages than individuals with other liver diseases, but the effect of age on liver transplantation (LT) outcomes in this population and whether it differs from other etiologies is not known. We aimed to evaluate the impact of age on LT outcomes in NASH.
READ MORE
Frontiers in Immunology
Organ gene therapy represents a promising tool to correct diseases or improve graft survival after transplantation. Polymorphic variation of the major histocompatibility complex (MHC) antigens remains a major obstacle to long-term graft survival after transplantation. Previously, we demonstrated that MHC-silenced cells are protected against allogeneic immune responses.
READ MORE
|
|
Transplant Infectious Disease via Wiley Online Library
Potential deceased organ donors are screened for human immunodeficiency virus (HIV‐1), hepatitis B virus (HBV) and hepatitis C virus (HCV) with serologic and nucleic acid tests (NAT). The results of these tests on the utilization of donors has not been directly measured.
Twenty six organ procurement organizations provided primary HIV, HBV, and HCV screening results and utilization information for donor referrals evaluated from 2004 to 2017.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
